Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib

PURPOSE: Tyrosine kinase inhibitors like sunitinib and sorafenib are commonly used to treat metastatic renal cell cancer patients. Cubilin is a membrane protein expressed in the proximal renal tubule. Cubilin and megalin function together as endocytic receptors mediating uptake of many proteins. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Niinivirta, Marjut, Enblad, Gunilla, Edqvist, Per-Henrik, Pontén, Fredrik, Dragomir, Anca, Ullenhag, Gustav J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427164/
https://www.ncbi.nlm.nih.gov/pubmed/28260162
http://dx.doi.org/10.1007/s00432-017-2365-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427164/
https://www.ncbi.nlm.nih.gov/pubmed/28260162
http://dx.doi.org/10.1007/s00432-017-2365-y

Ejemplares similares